Evidence map›Paper›PMID 37107238›Full record

ReviewAntioxidants (Basel, Switzerland)2023

Recent Applications of Melanin-like Nanoparticles as Antioxidant Agents.

Alexandra Mavridi-Printezi, Arianna Menichetti, Dario Mordini, Riccardo Amorati, Marco Montalti

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexandra Mavridi-PrinteziDepartment of Chemistry «Giacomo Ciamician», University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0000-0003-1807-4238
Arianna MenichettiDepartment of Chemistry «Giacomo Ciamician», University of Bologna, Via Selmi 2, 40126 Bologna, Italy.
Dario MordiniDepartment of Chemistry «Giacomo Ciamician», University of Bologna, Via Selmi 2, 40126 Bologna, Italy.
Riccardo AmoratiDepartment of Chemistry «Giacomo Ciamician», University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0000-0002-6417-9957
Marco MontaltiDepartment of Chemistry «Giacomo Ciamician», University of Bologna, Via Selmi 2, 40126 Bologna, Italy.ORCID 0000-0001-6227-0899
University of Bologna · IT

Funding

Ministry of Education, Universities and Research 2017E44A9P, 2020CBEYHC
6 · The paper itself

Abstract

Nanosized antioxidants are highly advantageous in terms of versatility and pharmacokinetics, with respect to conventional molecular ones. Melanin-like materials, artificial species inspired by natural melanin, combine recognized antioxidant (AOX) activity with a unique versatility of preparation and modification. Due to this versatility and documented biocompatibility, artificial melanin has been incorporated into a variety of nanoparticles (NP) in order to give new platforms for nanomedicine with enhanced AOX activity. In this review article, we first discuss the chemical mechanisms behind the AOX activity of materials in the context of the inhibition of the radical chain reaction responsible for the peroxidation of biomolecules. We also focus briefly on the AOX properties of melanin-like NP, considering the effect of parameters such as size, preparation methods and surface functionalization on them. Then, we consider the most recent and relevant applications of AOX melanin-like NPs that are able to counteract ferroptosis and be involved in the treatment of important diseases that affect, e.g., the cardiovascular and nervous systems, as well as the kidneys, liver and articulations. A specific section will be dedicated to cancer treatment, since the role of melanin in this context is still very debated. Finally, we propose future strategies in AOX development for a better chemical understanding of melanin-like materials. In particular, the composition and structure of these materials are still debated, and they present a high level of variability. Thus, a better understanding of the mechanism behind the interaction of melanin-like nanostructures with different radicals and highly reactive species would be highly advantageous for the design of more effective and specific AOX nano-agents.

Indexed as

allomelaninbioimagingferroptosisfluorescencemelaninnanomedicinenanoparticlespolydopamineradicalsROS

Identifiers

PMID37107238
PMCPMC10135245
OpenAlexW4362586886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.